Researchers find novel inhibitors that may suppress oncogenesis of metastatic prostate cancer

Researchers have found that treating prostate cancer cells with novel cyclin-dependent kinase 19 (CDK19) and homologous cyclin-dependent kinase 8 (CDK8) inhibitors reduces their potential to migrate into and invade surrounding structures.

Related Keywords

Germany ,Borstel ,Niedersachsen ,United States ,American ,Sven Perner ,Emily Henderson ,Leibniz Lung Center ,Institute Of Pathology ,University Hospital Schleswig Holstein ,Elsevier ,American Journal ,Lead Investigator ,Cancer ,Ncogenesis ,Prostate ,Prostate Cancer ,Androgen ,Fell ,Cyclin Dependent Kinase ,Homologous ,N Vitro ,Inase ,Metastasis ,Pathology ,Phosphorylation ,